Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor

Published:2021-09-12 Issue:21 Volume:10 Page:7492-7502
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Shen Haixiang¹^ORCID,Liu Jin²,Liu Wei³,Sun Jiazhu¹,Zheng Xiangyi¹^ORCID,Teng Lisong²^ORCID,Wang Xiao¹,Xie Liping¹

Affiliation:

1. Department of Urology First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China

2. Department of Surgical Oncology First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China

3. Department of Urology Zhongnan Hospital of Wuhan University Wuhan China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4270

Reference27 articles.

1. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy

4. Renal cell carcinoma

5. Systemic therapy for metastatic renal cell carcinoma: a review and update;Logan JE;Rev Urol,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiRNA-148a inhibits cell growth and drug resistance by regulating WNT10a expression in renal cell carcinoma;Translational Andrology and Urology;2022-07

2. Conditional survival of trimodal therapy for nonmetastatic muscle‐invasive bladder cancer: A SEER database analysis;Cancer Medicine;2022-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3